Bayer on Wednesday said it would be forced to stop its U.S. production of widely-used farming weedkiller glyphosate unless regulatory or legal changes are made to stave of litigation that has been weighing on the German company.
Bayer CEO: we will have to stop U.S. glyphosate production if nothing changes
Bayer adds $1.9 billion to Roundup litigation reserves, raises 2025 sales forecast
Bayer said on Thursday it had set aside an additional 1.2 billion euros (C$1.9 billion) in provisions to address ongoing litigation in the United States over weed killer Roundup.
French court finds complaint brought by family in Bayer glyphosate case inadmissible, media says
A French court ruled on Thursday that a complaint brought by a family against Bayer claiming their son's disabilities were the result of his mother’s exposure to glyphosate when pregnant was inadmissible, local media reported.
US Supreme Court seeks Justice Department views on Bayer Roundup appeal
Bayer has threatened to pull Roundup from the U.S. market if it’s not granted greater protections
The U.S. Supreme Court asked President Donald Trump's administration on Monday for its views on Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.
Bayer loses appeal of $611M Roundup verdict in Missouri
A Missouri appellate court has upheld a $611 million verdict awarded to three people who sued Bayer alleging that its Roundup weedkiller caused their cancer, a ruling the company says it will further appeal.
Bayer: U.S. Supreme Court could decide in June whether it will hear glyphosate case
The crop input giant is looking for greater protection against costly product liability lawsuits
Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the company's request to sharply limit costly litigation over disputed claims that its Roundup weedkiller causes cancer.
Bayer to exit US seed treatment equipment business, email says
Bayer committed to seed treatments but won’t manufacture seed treatment equipment, the company said
Bayer is exiting the seed treatment equipment business in the United States to help the company's finances, according to an email sent to customers that was seen by Reuters on Wednesday.
Bayer CEO: targeting US state regulation to stem glyphosate costs
Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weed killer glyphosate, the German chemicals company's CEO said in a draft speech released on Thursday.
Glyphosate class action moves forward in Canada
Bayer defends safety of the herbicide, but legal costs may force withdrawal from U.S. market
Multiple law firms across the country – in Saskatchewan, Ontario, British Columbia and elsewhere – are now recruiting Canadians to join a class action lawsuit related to Roundup and cases of non-Hodgkin’s lymphoma.
Bayer renews bid for US Supreme Court to curb glyphosate cases
Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup herbicide causes cancer, seeking to avoid potentially billions of dollars in damages.
Cyber-Savvy Farmer
